Hippocratic AI is an advanced AI tool tailored for healthcare, distinguishing itself by pre-training on trusted, evidence-based content, unlike most language models that rely on broader internet data, which can be unreliable. The company’s focus is to enhance healthcare access, equity, and outcomes by delivering safer, more effective language learning models (LLMs) specifically designed for healthcare applications. Hippocratic AI’s models are tested rigorously, outperforming GPT-4 in 105 out of 114 healthcare certifications and exams, demonstrating their superior understanding and application in medical contexts.
The development of Hippocratic AI involves a unique approach called Reinforcement Learning with Human Feedback (RLHF), where healthcare professionals help train and validate the model, ensuring its safety and effectiveness before release. This careful preparation aligns with the company’s commitment to delivering a product that healthcare professionals trust.
Hippocratic AI also emphasises the importance of compassionate communication in healthcare settings, planning to introduce benchmarks for evaluating the bedside manner of LLMs. This initiative reflects their broader goal to support not just clinical accuracy but also the emotional and psychological well-being of patients.
The startup has garnered significant investment, raising a total of $120 million to date, including a substantial $53 million Series A funding round. These funds support their ongoing product development and safety testing, underscoring their commitment to revolutionising healthcare with AI while prioritising safety and ethical considerations.